Literature DB >> 10560961

Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism.

M Rotondi1, C Caccavale, C Di Serio, A Del Buono, F Sorvillo, D Glinoer, A Bellastella, C Carella.   

Abstract

Severe hypothyroidism was discovered in a young woman in her 29th week of pregnancy. Previously, at the age of 12 years, she had undergone thyroid surgery for Graves' disease that resulted in persistent hypothyroidism and hypoparathyroidism. After surgical excision, the patient started levothyroxine replacement therapy and had regular control of thyroid function with normal findings throughout the years. The dose of levothyroxine had not been adjusted when the pregnancy started, and at the 29th week of gestation the patient had a thyrotropin (TSH) of 72.4 microU/mL. Ultrasound studies were performed in order to monitor fetal development. The fetal parameters analyzed before the adjustment of levothyroxine therapy showed growth retardation of various degrees. All analyzed fetal parameters (biparietal diameter, cranial and abdominal circumference, humerus and femur length) improved during the last 6 weeks of gestation, showing a good correlation with the newly achieved euthyroid state of the mother. The infant was clinically euthyroid at birth and was found normal at all evaluations of the neonatal hypothyroidism screening program (1, 5, 30 days).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560961     DOI: 10.1089/thy.1999.9.1037

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  2 in total

1.  Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait.

Authors:  Daniela Pasquali; Marco Carotenuto; Paola Leporati; Maria Esposito; Lorenzo Antinolfi; Daniela Esposito; Giacomo Accardo; Carlo Carella; Luca Chiovato; Mario Rotondi
Journal:  Endocrine       Date:  2015-03-06       Impact factor: 3.633

Review 2.  Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review.

Authors:  M R Boland; N P Tatonetti
Journal:  Pharmacogenomics J       Date:  2016-07-12       Impact factor: 3.550

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.